4//SEC Filing
Pulmatrix, Inc. 4
Accession 0000899243-17-008411
$PULMCIK 0001574235operating
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 6:49 PM ET
Size
9.9 KB
Accession
0000899243-17-008411
Insider Transaction Report
Form 4
Pulmatrix, Inc.PULM
Hava David L.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2017-03-22$2.21/sh+2,263$5,001→ 2,263 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-03-22−2,263→ 1,292 totalExercise: $2.21Exp: 2020-02-10→ Common Stock (2,263 underlying) - Award
Stock Option (Right to Buy)
2017-03-20+75,100→ 75,100 totalExercise: $2.78Exp: 2027-03-20→ Common Stock (75,100 underlying)
Footnotes (3)
- [F1]The option vests as to 25% on March 20, 2018 and the remaining 75% vests in thirty-six (36) equal monthly installments with 2.083% vesting for each of the next thirty-six (36) months that follow March 20, 2018, subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan.
- [F2]The option, representing the right to purchase a total of 3,555 shares of common stock, was fully vested and exercisable as of February 10, 2014.
- [F3]On March 22, 2017, the Reporting Person acquired 2,263 shares of common stock upon a partial exercise of this option. Following the exercise, the Reporting Person may acquire an additional 1,292 shares of common stock pursuant to this option.
Documents
Issuer
Pulmatrix, Inc.
CIK 0001574235
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001574235
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 6:49 PM ET
- Size
- 9.9 KB